MPT Company Profile and Key Details

Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 0 Buy ratings, 2 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $5.00 to $4.50. The high target offers 38.89% upside. The low target suggests 25.0% downside. The mean target is $4.83. This offers 34.17% upside. Medical Properties Trust, Inc. earnings surprise history is a mixed track record. The quarter that ended August 10, 2026, missed forecasts by 322.91%. The prior quarter beat by 81.82%. Over the last six quarters, Apple has recorded several small beats. These include -6.67% in May 01, 2025.

Medical Properties Trust, Inc. has 597.20 million shares outstanding. The public float is 489.75 million shares, elevated short interest at 32.36% of float. This equals 144.27 million shares. The short ratio is 27.04 days. Institutional investors hold 72.67% of the float. Insiders own 17.52%. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Short-term trend indicators are bearishly aligned (SMA20 6.02%, SMA50 10.15%, SMA200 19.18%). The stock’s 14-day RSI is 60.63 (firm momentum), while the ATR of 0.22 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -10.2% below its high and over 47.09% above its low. Average 10-day trading volume of 12.47 million shares is significantly above the 3-month average of 7.70 million, indicating heightened recent market interest.

Medical Properties Trust, Inc. last paid a dividend of 0.36 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.35. This means the shares are trading near this model’s fair value.

Medical Properties Trust, Inc. (NYSE:MPT) closed at $3.42 USD, losing -$0.18 (-4.86%) from the previous close of $3.60. The stock is currently within 5% of its 52-week low $3.39 and $6.47. With a market capitalization of about $2.05 billion, Medical Properties Trust, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.44). Key stats such as the average daily volume over the past year has been around 7.67 million shares, in line with its 52-week average. Headquartered in Birmingham, AL, Medical Properties Trust, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Edward K. Aldag Jr., the company employs approximately 121 people and listed since July 07, 2005. Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT).

Medical Properties Trust, Inc. trades at a P/E ratio of -69.54, slightly below the S&P 500 average, with a price-to-sales ratio of 2.14 and a price-to-book ratio of 0.49 suggesting the stock is closer to book value. The P/FCF stands at 9.63, also above market averages.

currently trading near 52-week highs band. Valuation shows Medical Properties Trust, Inc. trading at a premium to the broader market with a P/E of -69.54. Analyst sentiment is cautious, with the majority of ratings in Underweight territory and a mean price target of $4.83, suggesting 34.17% upside. Our AI forecast model points to short-term weakness (-9.72% over two weeks), a medium-term fall (-76.94% over three months), and a longer-term loss (-94.72% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Medical Properties Trust, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.72%, with price expected at $3.25 by October 01, 2026, within a range of $3.09 to $3.40 3-Month Outlook: Projected fall of -76.94%, reaching $0.83 by December 16, 2026, with a range of $0.64 to $1.02. 1-Year Outlook: Projected loss of -94.72%, with price at $0.19 by September 17, 2027, within a range of $0.01 to $0.36.